Hepatology

To improve screening efficiency, it is crucial to identify patients with elevated hepatocellular carcinoma risk while sparing low-risk individuals from unnecessary procedures.

A randomised controlled trial showed that adding reduced glutathione to entecavir therapy can significantly improve liver function, reduce fibrosis, and enhance HBV-DNA clearance in chronic hepatitis B patients.

Immunotherapy, targeted radiation, and a refined surgical technique allowed tumour removal in a liver cancer patient previously ineligible for surgery.

Findings suggest that combining simvastatin and rifaximin does not offer a clinically meaningful advantage in preventing severe complications in patients with decompensated cirrhosis.

Even low levels of air pollution can cause liver inflammation, fibrosis, and metabolic changes linked to fatty liver disease.

cCR predicts survival outcomes in unresectable hepatocellular carcinoma, providing a valuable marker for treatment response and prognosis.

This study revealed an association between elevated hepatic histamine levels, mast cell infiltration, and erythropoietic protoporphyria progression.

Non-selective β-blockers have demonstrated significant potential in preventing decompensation.